Joint OIE/WHO/EU Conference on rabies:
Towards the Elimination of rabies in
Eurasia
27-30 May 2007, Paris, France
Programme
Sunday, 27 May 2007
OIE Headquarters, Salle Vittoz
16h00
Registration
18h00
Opening Ceremony
Chairperson: G. Brückner (OIE, France)
Welcome: Speech of the representatives of the three co-organising bodies
B. Vallat (OIE)
F.-X. Meslin (WHO)
J.-P. Vermeersch (EU)
Keynote address
J. Blancou
Towards the elimination of rabies in Eurasia: Overview and perspectives
19h00
OIE Welcome cocktail
Monday, 28 May 2007
OIE Headquarters, Salle Vittoz
09h00 - Session 1 / Epidemiological information. Rabies in Eurasia: Regional reports
Chairperson: V. Caporale (IZS, Italy) - Rapporteur: B. Dodet (IABs, Switzerland)
09h00 Rabies situation in Western Europe
A.I. Wandeler (CFIA/ACIA,
Canada)
09h12 Rabies situation in Eastern Europe
O. Matouch (NRLR, Czech Rep.)
09h24 Rabies situation in Central Asia
K.N.Gruzdev (FGI-ARRIAH,
Russia)
1/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
09h36 Rabies situation in the Middle East
A. Seimenis (WHO)
09h48 Rabies situation in Far East Asia
Z.F. Fu (UG, USA)
10h00 Discussion
10h30 Coffee break
11h00 - Session 2 / Rabies pathogenesis
Chairperson: A.C. Jackson (KGH, Canada) - Rapporteur: M. Lafon (IP, France)
11h00 Cytokine expression in the CNS and periphery
N. Johnson (VLA, UK)
during infection with rabies
11h10 Neuroimaging, virus and cytokine studies in
T. Hemachudha (CU, Thailand)
rabies infected dogs
11h20 Role of Calcitonin Gene-Related Peptide (CGRP)
E. Weihe (UM,
Germany)
in the pathogenesis of rabies
11h30 Pathogenic and attenuated rabies viruses
Z.F. Fu (UG, USA)
induces differential host protein expression in
the central nervous system: Implication of
neuronal dysfunction
11h40 Dominance of a non-pathogenic over a pathogenic
B. Dietzschold (TJU,
USA)
G protein gene in defining the pathogenicity of
a rabies virus
11h50 Discussion
12h00 Lunch break
13h30 - Session 3 / Rabies prevention and control strategies
13h30
Keynote speech: Can rabies be eradicated?
C. Rupprecht (CDC, USA)
14h00 - Rabies control in dogs
Chairperson: F. Cliquet (AFSSA, France) - Rapporteur: B.A. Yakobson (KVI, Israël)
14h00 Molecular epidemiology of lyssaviruses in
Eurasia
14h10 Identification of novel canine rabies virus
L.M. McElhinney (VLA, UK)
D. David, (KVI, Israël)
clades in the middle east and north africa
2/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
14h20 Rabies in South Asia - Epidemiological
C.K. Singh (RRDL, India)
investigations
14h30 Stray dogs in Bangkok, Thailand: rabies virus
S. Kasempimolporn (QSMI, Thailand)
infection and rabies antibody prevalence
14h40 Preference for commercially produced oral
D. Bergman (USDA, USA)
rabies baits by feral dogs
14h50 Assessment of the efficacy of oral vaccination
B.A. Yakobson (KVI, Israël)
of shepherd dogs in supplement of oral rabies
vaccination of wild canids in israel
15h00 Longterm immunization of recombinant rabies-
R. Hu (AMMS,China)
canine adenovirus type-2 in dogs after intranasal
or oral vaccination
15h10 New steps in the control of canine rabies in
India
H.K. Pradhan (IVRI,India)
F.-X. Meslin (WHO)
15h20 Rabies in Mexico, 1990-2005
C.H. Álvarez Lucas (SM, Mexico)
15h30 Risk of rabies introduction by non-commercial
P. Have (EFSA)
movement of pets
15h40 Discussion
16h00 Coffee break
16h30 - Rabies control in wildlife
Chairperson: A.D. Botvinkin (ISMV, Russia) - Rapporteur: I. Kuzmin (CDC, USA)
16h30 Epidemiology of rabies in South East Europe
N. Johnson (VLA, UK)
16h40 Rabies in Mongolian steppes
A.D. Botvinkin (ISMV, Russia)
16h50 Epidemiology and control of rabies in Iran
A.R. Janani (PI, Iran)
17h00 Rabies epidemiology in Raccoon Dogs and Foxes
17h10 Downside risk of wildlife translocation
17h20 Sylvatic rabies in Russia with special attention to
A. Singer (CSL, UK)
R. Chipman (USDA, USA)
A.D. Botvinkin (ISMV,
Russia)
perspectives of oral vaccination of wild carnivores
17h30 Finnish-Russian collaboration programme on
A. Metlin (FGI ARRIAH, Russia)
rabies control in wildlife: the outcome of five
years and the future prospects
3/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
17h40 Rabies eradication programme in Estonia by
M. Laine (FB, Estonia)
means of oral vaccination of wildlife: first results
17h50 Rabies surveillance in Poland between 1992 –
M. Smreczak (NVRI, Poland)
2006
18h00 Efficacy of a square presentation of V-RG vaccine
F. Cliquet (AFSSA, France)
baits in red fox, domestic dog and raccoon dog
18h10 Scenario-analysis evaluating emergency strategies
H.-H. Thulke (HCER,
Germany)
after rabies re-introduction
18h20 The financial challenge to keep a large region
T. Müller (FLI, Germany)
free of rabies – the EU example
18h30 What is the future of rabies control in Europe?
18h40 The strength of 70% - Revising a given threshold
G. Smith (CSL, K)
H.-H. Thulke (HCER,
Germany)
of rabies control
18h50 Discussion
Tuesday, 29 May 2007
09h00 - Rabies in bats: an emerging zoonosis
Chairperson: A.R. Fooks (VLA, UK) - Rapporteur: T. Müller (FLI, Germany)
09h00 A random grid based molecular epidemiological
C. Freuling (FRIAH,
Germany)
study on EBLV isolates from Germany
09h10 Asymptomatic rhabdovirus infection in meridional
J.E. Echevarría Mayo (ISC,
Spain)
serotine bats (Eptesicus isabellinus) from Spain
09h20 Public health hazard of European bat lyssavirus,
W.H.M. Van der Poel (WUR,
Netherlands)
the Netherlands
09h30 Serological investigation of bats infected with
C. Tu (AMMS, China)
rabies virus in China
09h40 Epidemiology and pathogenicity of African bat
L.H. Nel (UP, South Africa)
lyssaviruses
4/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
09h50 Experimental infection of big brown bats
I. Kuzmin (CDC, USA)
(Eptesicus fuscus) with West Caucasian bat virus
10h00 Susceptibility of foxes (Vulpes vulpes) to European
E. Picard, (AFSSA, France)
bat lyssaviruses types-1 and -2
10h10 Identification of british bat species using sequence
S.L. Harris (UB, UK)
comparison and its application to european bat
lyssavirus diagnosis and surveillance
10h20 Discussion
10h30 Coffee break
11h00 - Rabies prevention in humans
Chairperson: F.-X. Meslin (WHO) - Rapporteur: Y. Rotivel (IP, France)
11h00 Human rabies includes early generalized
R. Willoughby (CHW, USA)
vasospasm of cranial arteries that responds to
tetrahydrobiopterin, l-arginine or nitroprusside
11h10 Therapy of human rabies: lessons from experimental
A.C. Jackson (KGH, Canada)
studies in a mouse model
11h20 Rabies control and prevention in the republic of
P. Imnadze (NCCD, Georgia)
Georgia: current status and perspectives
11h30 A simplified economical 4-site intradermal
M. Warrell (UO, UK)
post-exposure rabies vaccine regimen is as
immunogenic as the current intramuscular and
intradermal methods
11h40 Single dose for rabies pre-immunization
P. Khawplod (QSMI, Thailand)
11h50 Immune memory after remote pre- and
H. Wilde (CU, Thailand)
post-exposure rabies vaccination: a prospective
study in thailand
12h00 Epidemiology and prophylaxis of rabies in humans
Y. Rotivel (IP, France)
in France. Evaluation and perspectives of a twenty
five year surveillance program
12h10 Discussion
12h30 Lunch break
14h00 - Session 4 / Advances in technologies, diagnosis and vaccines
Chairperson: N. Tordo (IP, France) - Rapporteur: T. Hemachuda (CU, Thailand)
5/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
14h00
Keynote speech: Immune evasion, a critical strategy
for rabies virus
14h30 BHK-21 cell culture rabies vaccine- a candidate
M. Lafon (IP, France)
D. Lalosevic (FMNS, Serbia)
vaccine for Humans
14h40 Factors influencing the antibody response to
V. Jakel (JLU, Germany)
rabies vaccination
14h50 Attaining raccoon rabies management goals:
D. Slate (USDA, USA)
history and challenges
15h00 Evaluation of the stability of rabies vaccine baits
P. Maciulskis (LVA,
Lithuania)
field trial
15h10 Immunogenicity of ERA G 333 strain in foxes and
D. Bankovskiy (ARRI, Russia)
raccoon dogs
15h20 Canine adenovirus-based vaccines against rabies
N. Tordo (IP, France)
15h30 Coffee break
16h00 Development of an edible rabies vaccine in maize,
E. Loza-Rubio (NCVM, Mexico)
using vnukovo strain
16h10 Genetically engineered single-chain antibody
M. Mousli (IP, Tunisia)
fusion proteins for detection of rabies virus antigen
16h20 Use of rabies virus as a transneuronal tracer of
G. Ugolini (CNRS, France)
neuronal connections: Implications for the
understanding of rabies pathogenesis
16h30 Inhibition of rabies virus replication by Micro-RNA
N. Israsena (CUHR, Thailand)
16h40 Discussion
17h00
Keynote speech: Rabies at the dawn of the 21st
Century
H. Koprowski (TJU, USA)
Wednesday, 30 May 2007
09h00 - Session 5 / General conclusions and recommendations
Chairperson: N. Belev (OIE) - Rapporteur: T. Müller (FLI, Germany) and A.R. Fooks
(VLA, UK)
10h00 Coffee break
6/7
Joint OIE/WHO/EU Conference on rabies, 27-30 May 2007 - Programme
10h30 Report of the questionnaire on stray dog control
S. Kahn (OIE,
France)
10h40
Keynote speech: What have we achieved?
The way forward
D. Briggs (VMC, USA)
11h15 Announcement and video of the next conference
11h30 Closing of the conference
13h00 Press point
7/7